dsRNA as broad-spectrum antiviral therapeutics DOI Creative Commons
Cong‐Fei Xu

Molecular Therapy — Nucleic Acids, Год журнала: 2022, Номер 30, С. 270 - 271

Опубликована: Окт. 19, 2022

The human immune system can detect the presence of foreign double-stranded RNA (dsRNAs) and activates innate response against viral invaders by boosting secretion cytokines called interferons (IFN). In this issue, Si et al. have found a new class immunostimulatory dsRNAs that potently promote production two kinds IFN (IFN-I IFN-III) while reducing inflammation often observed with known types immunostimulants.1Si L. Bai H. Oh C.Y. Jiang A. Hong F. Zhang T. Ye Y. Jordan T.X. Logue J. McGrath M. al.Self-assembling short duplex RNAs broad-spectrum antiviral activity.Mol. Ther. Nucleic Acids. 2022; 29: 923-940Abstract Full Text PDF PubMed Scopus (3) Google Scholar When dsRNA molecules were tested in traditional cell culture as well complexed Human Organ Chip model lung faithfully mimics its vivo counterpart, they inhibited infection many viruses pandemic potential, such SARS-CoV, SARS-CoV-2, MERS-CoV, various influenza A strains. mouse COVID-19, decreased virus more than 1,000-fold. This technology has potential to become broadly applied approach for combating future pandemics. discovery was made inadvertently when interfering (siRNA) sequences developed "knock down" host genes determine how affected infection. researchers discovered mixture three siRNAs prevented cells 90% lowered gene named DGCR5 80%. However, subsequent analysis revealed effect side siRNA not direct DGCR5. specific sequence, which is 25–27 nucleotides, induced overexpression numerous involved signaling pathway. particularly noteworthy due fact employing purposefully devoid recognized immune-stimulating structural characteristics. Additional study indicated particular exclusively triggered RIG-I pathway, but other downstream pathways (TLR3 or MDA5). To better understand mechanism action type previously unidentified RNA, 200 then generated tease out what driving stimulation. They identified nucleotide sequence motif, occurred on ends similar high activity: cytosine (C) one strand guanines (GGG) strand. motif's position within molecule modified, lost their effects, confirming it crucial element activation. Because C GGG elements motif are different lengths, end each an "overhang" guanines. copies present, four these bind via unusual phenomenon G-G Hoogsteen base pairing. resulting dimers effectively, causing efficacy newly living cells, pitted them poly (I:C), widely used immunostimulant activate cellular sensors, including TLR3, RIG-I, MDA5. administered epithelial produced restricted, less inflammatory response, whereas (I:C) caused far larger changes expression biological processes needed normal function. Subsequently, team Lung Airway Alveolus replicate function responses infections vitro.2Bai Belgur C. Zhai Plebani R. Rodas Patil Nurani al.Mechanical control alveolus chip.Nat. Commun. 13: 1928Crossref (24) Scholar,3Bai Ingber D.E. What organ-on-a-chip teach us about pathophysiology?.Physiology. 37: 000Crossref (5) Scholar,4Si Cao W. Moller Hoagland D. Oishi K. Horiuchi S. al.A human-airway-on-a-chip rapid identification candidate therapeutics prophylactics.Nat. Biomed. Eng. 2021; 5: 815-829Crossref (156) transfected into healthy chips saw 12- 40-fold increase IFN-beta expression. injected organ chips, 80%–90%. COVID-19 evident we need therapies attenuate wide range viruses, rather designing tailored therapy illness emerges. So, related coronaviruses HCoV-NL63. mammalian line, MERS-CoV HCoV-NL63 90%, SARS-CoV Furthermore, SARS-CoV-2 lines 99.99%. Finally, evaluated COVID-19. mice infected burden factor 1,000 delivered intravenously. addition treating infections, treat bacterial, fungal, parasite diseases cancer could benefit from production. Additionally, be employed adjuvant boost vaccinations. research required identify best time treatment, activating too late may aggravate inflammation. Better routes delivering reduce systemic activation., example, directly upper airway, also translate treatment.

Язык: Английский

Pathology and pathobiology of pulmonary hypertension: current insights and future directions DOI Creative Commons
Christophe Guignabert, Jurjan Aman, Sébastien Bonnet

и другие.

European Respiratory Journal, Год журнала: 2024, Номер 64(4), С. 2401095 - 2401095

Опубликована: Авг. 29, 2024

In recent years, major advances have been made in the understanding of cellular and molecular mechanisms driving pulmonary vascular remodelling various forms hypertension, including arterial hypertension associated with left heart disease, chronic lung disease hypoxia, thromboembolic hypertension. However, survival rates for these different remain unsatisfactory, underscoring crucial need to more effectively translate innovative scientific knowledge into healthcare interventions. proceedings 7th World Symposium on Pulmonary Hypertension, we delve developments field pathology pathophysiology, prioritising them while questioning their relevance subsets addition, explore how latest omics other technological can help us better rapidly understand myriad basic contributing initiation progression remodelling. Finally, discuss strategies aimed at improving patient care, optimising drug development, providing essential support advance research this field.

Язык: Английский

Процитировано

28

Microfluidic trends in drug screening and drug delivery DOI Open Access
Jianguo Feng, Jiřı́ Neužil, A. Manz

и другие.

TrAC Trends in Analytical Chemistry, Год журнала: 2022, Номер 158, С. 116821 - 116821

Опубликована: Ноя. 14, 2022

Язык: Английский

Процитировано

49

Organ‐on‐a‐chip technologies for biomedical research and drug development: A focus on the vasculature DOI Creative Commons
Diosángeles Soto Véliz, Kai‐Lan Lin, Cecilia Sahlgren

и другие.

Smart Medicine, Год журнала: 2023, Номер 2(1)

Опубликована: Фев. 1, 2023

Abstract Current biomedical models fail to replicate the complexity of human biology. Consequently, almost 90% drug candidates during clinical trials after decades research and billions investments in development. Despite their physiological similarities, animal often misrepresent responses, instead, trigger ethical societal debates regarding use. The overall aim across regulatory entities worldwide is replace, reduce, refine use experimentation, a concept known as Three Rs principle. In response, researchers develop experimental alternatives improve biological relevance vitro through interdisciplinary approaches. This article highlights emerging organ‐on‐a‐chip technologies, also microphysiological systems, with focus on vasculature. cardiovascular system transports all necessary substances, including drugs, throughout body while charge thermal regulation communication between other organ systems. addition, we discuss benefits, limitations, challenges widespread new models. Coupled patient‐derived induced pluripotent stem cells, technologies are future discovery, development, personalized medicine.

Язык: Английский

Процитировано

31

Patient-derived organoids in precision cancer medicine DOI Creative Commons
Le Tong, Weiyingqi Cui, Boya Zhang

и другие.

Med, Год журнала: 2024, Номер unknown

Опубликована: Сен. 1, 2024

Язык: Английский

Процитировано

13

Intestinal organ chips for disease modelling and personalized medicine DOI
Aliçan Özkan, Nina LoGrande, Jéssica F. Feitor

и другие.

Nature Reviews Gastroenterology & Hepatology, Год журнала: 2024, Номер 21(11), С. 751 - 773

Опубликована: Авг. 27, 2024

Язык: Английский

Процитировано

10

Biomimetic In Vitro Lung Models: Current Challenges and Future Perspective DOI Creative Commons
Ali Doryab, Jürgen Gröll

Advanced Materials, Год журнала: 2023, Номер 35(13)

Опубликована: Фев. 7, 2023

As post-COVID complications, chronic respiratory diseases are one of the foremost causes mortality. The quest for a cure this recent global challenge underlines that lack predictive in vitro lung models is main bottlenecks pulmonary preclinical drug development. Despite rigorous efforts to develop biomimetic models, current cutting-edge represent compromise numerous technological and biological aspects. Most advanced still "proof-of-concept" phase with low clinical translation findings. On other hand, advances cellular molecular studies mainly based on relatively simple unrealistic models. Herein, challenges potential strategies toward not only bioinspired but truly discussed.

Язык: Английский

Процитировано

19

3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics DOI Open Access
Roberto Plebani, Haiqing Bai, Longlong Si

и другие.

International Journal of Molecular Sciences, Год журнала: 2022, Номер 23(17), С. 10071 - 10071

Опубликована: Сен. 3, 2022

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the disease 2019 (COVID-19), has provoked more than six million deaths worldwide and continues to pose a major threat global health. Enormous efforts have been made by researchers around world elucidate COVID-19 pathophysiology, design efficacious therapy develop new vaccines control pandemic. To this end, experimental models are essential. While animal conventional cell cultures widely utilized during these research endeavors, they often do not adequately reflect human responses SARS-CoV-2 infection. Therefore, that emulate with high fidelity infection in organs needed for discovering antiviral drugs against COVID-19. Three-dimensional (3D) cultures, such as lung organoids bioengineered organs-on-chips, emerging crucial tools on diseases. The airway, small airway alveolus organ chips successfully used studies response various pathogens, including corona influenza A viruses. In review, we provide an overview of their use pathogenesis drug testing. We also discuss limitations existing indicate some improvements well future epidemics.

Язык: Английский

Процитировано

22

Towards a gold standard functional readout to characterize In Vitro lung barriers DOI Creative Commons
Ali Doryab, Otmar Schmid

European Journal of Pharmaceutical Sciences, Год журнала: 2022, Номер 179, С. 106305 - 106305

Опубликована: Окт. 8, 2022

The development of biomimetic in vitro lung models as an alternative to animal studies is urgent improve the predictability pharmacokinetics potential new drugs. For studies, advanced such lung-chips should mimic a functional air-blood barrier. Unlike vivo conditions, stem/primary cells and cell lines do not necessarily form tight barrier when cultured vitro. Here, we explore two gold standard techniques for monitoring integrity: transepithelial electrical resistance (TEER) permeability. We discuss advantages limitations these methods, provide recommendations methodological improvements, elude on possible future directions.

Язык: Английский

Процитировано

17

A bionic controllable strain membrane for cell stretching at air–liquid interface inspired by papercutting DOI Creative Commons

Yuanrong Li,

Mingjun Xie,

Shang Lv

и другие.

International Journal of Extreme Manufacturing, Год журнала: 2023, Номер 5(4), С. 045502 - 045502

Опубликована: Авг. 11, 2023

Abstract Lung diseases associated with alveoli, such as acute respiratory distress syndrome, have posed a long-term threat to human health. However, an in vitro model capable of simulating different deformations the alveoli and suitable material for mimicking basement membrane are currently lacking. Here, we present innovative biomimetic controllable strain (BCSM) at air–liquid interface (ALI) reconstruct alveolar respiration. The BCSM consists high-precision three-dimensional printing melt-electrowritten polycaprolactone (PCL) mesh, coated hydrogel substrate—to simulate important functions (such stiffness, porosity, wettability, ALI) microenvironments, seeded pulmonary epithelial cells vascular endothelial on either side, respectively. Inspired by papercutting, was fabricated plane while it operated three dimensions. A series topological structure designed control various local-area strain, varied deformation. Lopinavir/ritonavir could reduce Lamin expression under over-stretch condition, which might be effective preventing ventilator-induced lung injury. lung-unit has broader application prospects alveoli-related research future, drug toxicology metabolism.

Язык: Английский

Процитировано

5

Lack of racial and ethnic diversity in lung cancer cell lines contributes to lung cancer health disparities DOI Creative Commons

Christopher C. Leon,

Eugene Manley,

Aaron Neely

и другие.

Frontiers in Oncology, Год журнала: 2023, Номер 13

Опубликована: Ноя. 1, 2023

Lung cancer is the leading cause of death in United States and worldwide, a major source health disparities. cell lines provide key

Язык: Английский

Процитировано

4